(Q26765951)

3 April 2019

22 April 2019

19 September 2019

12 October 2019

18 October 2019

2 August 2020

on focus list of Wikimedia project

22 August 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Immunity, Inflammation, and Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Inflammation and cancer: back to Virchow?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Acute-phase proteins and other systemic responses to inflammation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

European guidelines on upper tract urothelial carcinomas: 2013 update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The efficacy of the EORTC scoring system and risk tables for the prediction of recurrence and progression of non-muscle-invasive bladder cancer after intravesical bacillus calmette-guerin instillation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Nomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

The role of C-reactive protein as a prognostic indicator in advanced cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Serum albumin: a prognostic indicator in patients with colorectal cancer

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Low preoperative serum albumin in colon cancer: a risk factor for poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F8345286

Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4736380

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy

28 November 2018

1 reference

12 December 2020

The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer

1 reference

12 December 2020

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

1 reference

12 December 2020

Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome

1 reference

12 December 2020

C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy

1 reference

12 December 2020

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

1 reference

12 December 2020

The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

1 reference

12 December 2020

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

12 December 2020

Is C-reactive protein a prognostic factor of colorectal cancer?

1 reference

12 December 2020

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer

1 reference

12 December 2020

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment

1 reference

12 December 2020

Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up

1 reference

12 December 2020

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

12 December 2020

A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy

1 reference

12 December 2020

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

1 reference

12 December 2020

Non-muscle invasive bladder cancer

1 reference

12 December 2020

Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer

1 reference

12 December 2020

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

1 reference

12 December 2020

The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

1 reference

12 December 2020

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy

1 reference

12 December 2020

Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer

1 reference

12 December 2020

External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

1 reference

12 December 2020

Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer

1 reference

12 December 2020

Is serum albumin an independent predictor of survival in patients with breast cancer?

1 reference

12 December 2020

The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study

1 reference

12 December 2020

Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors

1 reference

12 December 2020

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

1 reference

12 December 2020